BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37131332)

  • 1. Intra-Abdominal and Retroperitoneal Benign Lipomatous Tumors-An Extremely Rare Mimic of Liposarcoma and its Diagnostic Challenge.
    Malik F; Allbee AW; Zhang PJ
    Int J Surg Pathol; 2024 Feb; 32(1):46-57. PubMed ID: 37131332
    [No Abstract]   [Full Text] [Related]  

  • 2. Sensitivity of MDM2 amplification and unexpected multiple faint alphoid 12 (alpha 12 satellite sequences) signals in atypical lipomatous tumor.
    Kashima T; Halai D; Ye H; Hing SN; Delaney D; Pollock R; O'Donnell P; Tirabosco R; Flanagan AM
    Mod Pathol; 2012 Oct; 25(10):1384-96. PubMed ID: 22699518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR.
    Sirvent N; Coindre JM; Maire G; Hostein I; Keslair F; Guillou L; Ranchere-Vince D; Terrier P; Pedeutour F
    Am J Surg Pathol; 2007 Oct; 31(10):1476-89. PubMed ID: 17895748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry.
    Kammerer-Jacquet SF; Thierry S; Cabillic F; Lannes M; Burtin F; Henno S; Dugay F; Bouzillé G; Rioux-Leclercq N; Belaud-Rotureau MA; Stock N
    Hum Pathol; 2017 Jan; 59():34-40. PubMed ID: 27597521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16 Expression in Fat Necrosis: A Potential Diagnostic Pitfall in the Evaluation of Differentiated Adipocytic Neoplasms.
    Ng W; Messiou C; Smith M; Thway K
    Int J Surg Pathol; 2015 Oct; 23(7):544-8. PubMed ID: 26173427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma With Features Mimicking Spindle Cell Lipoma.
    Jebastin JAS; Perry KD; Chitale DA; Mott MP; Sanchez J; Fritchie KJ; Palanisamy N; Williamson SR
    Int J Surg Pathol; 2020 May; 28(3):336-340. PubMed ID: 31672072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of MDM2/CDK4 amplification in lipomatous soft tissue tumors from formalin-fixed, paraffin-embedded tissue: comparison of multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH).
    Creytens D; van Gorp J; Ferdinande L; Speel EJ; Libbrecht L
    Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):126-33. PubMed ID: 25679065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD10 (neprilysin) expression: a potential adjunct in the distinction of hibernoma from morphologic mimics.
    Gjorgova-Gjeorgjievski S; Fritchie K; Folpe AL
    Hum Pathol; 2021 Apr; 110():12-19. PubMed ID: 33406387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDM2 Amplification in Problematic Lipomatous Tumors: Analysis of FISH Testing Criteria.
    Clay MR; Martinez AP; Weiss SW; Edgar MA
    Am J Surg Pathol; 2015 Oct; 39(10):1433-9. PubMed ID: 26146760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers.
    Shimada S; Ishizawa T; Ishizawa K; Matsumura T; Hasegawa T; Hirose T
    Hum Pathol; 2006 Sep; 37(9):1123-9. PubMed ID: 16938516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hibernoma Mimicking Atypical Lipomatous Tumor: 64 Cases of a Morphologically Distinct Subset.
    Al Hmada Y; Schaefer IM; Fletcher CDM
    Am J Surg Pathol; 2018 Jul; 42(7):951-957. PubMed ID: 29629919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical value of fluorescence
    Wang W; Li X; Liu P; Dong Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):228-233. PubMed ID: 37042132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDM2 and CDK4 Immunohistochemistry: Should It Be Used in Problematic Differentiated Lipomatous Tumors?: A New Perspective.
    Clay MR; Martinez AP; Weiss SW; Edgar MA
    Am J Surg Pathol; 2016 Dec; 40(12):1647-1652. PubMed ID: 27508976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Giant lipomas or retroperitoneal liposarcomas? Controversies in their diagnosis and treatment].
    Fernández Hernández JÁ; Navarro-Barrios Á; Gil Vázquez PJ; Gil JE; Varona Garcíal L; López Motos D; Fernández Selles C; Nieto G; Frutos Bernal MD; Torres Salmerón G; Soria Cogollos T
    Rev Esp Patol; 2021; 54(2):75-84. PubMed ID: 33726894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms.
    Weaver J; Downs-Kelly E; Goldblum JR; Turner S; Kulkarni S; Tubbs RR; Rubin BP; Skacel M
    Mod Pathol; 2008 Aug; 21(8):943-9. PubMed ID: 18500263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical lipomatous tumor/well differentiated liposarcoma and related mimics with updates. When is molecular testing most cost-effective, necessary, and indicated?
    Kilpatrick SE
    Hum Pathol; 2024 May; 147():82-91. PubMed ID: 38135062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboxypeptidase M: a biomarker for the discrimination of well-differentiated liposarcoma from lipoma.
    Erickson-Johnson MR; Seys AR; Roth CW; King AA; Hulshizer RL; Wang X; Asmann YW; Lloyd RV; Jacob EK; Oliveira AM
    Mod Pathol; 2009 Dec; 22(12):1541-7. PubMed ID: 19820690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical spindle cell lipoma: a clinicopathologic, immunohistochemical, and molecular study emphasizing its relationship to classical spindle cell lipoma.
    Creytens D; van Gorp J; Savola S; Ferdinande L; Mentzel T; Libbrecht L
    Virchows Arch; 2014 Jul; 465(1):97-108. PubMed ID: 24659226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipomas of the Oral Cavity: Utility of MDM2 and CDK4 in Avoiding Overdiagnosis as Atypical Lipomatous Tumor.
    Stojanov IJ; Mariño-Enriquez A; Bahri N; Jo VY; Woo SB
    Head Neck Pathol; 2019 Jun; 13(2):169-176. PubMed ID: 29748845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative MDM2/CDK4 immunoreactivity does not fully exclude MDM2/CDK4 amplification in a subset of atypical lipomatous tumor/ well differentiated liposarcoma.
    Machado I; Vargas AC; Maclean F; Llombart-Bosch A
    Pathol Res Pract; 2022 Apr; 232():153839. PubMed ID: 35303521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.